Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2
...
33 34 35 36 37 38 39 40 41
...
43 44 Next >
Economic Indicators Rise More Than Expected
The Conference Board's index of leading economic indicators rose more than expected to lift the markets higher during the midday with the Dow climbing 68 points to 8812. Nasdaq gained 15 points to... 
Tags Market News
From MarketMinute.com Market Updates
Deal payment carves into Biogen Idec's profit
Biogen Idec reports lower second-quarter earnings, due in part to a payment to Acorda Therapeutics under a newly signed partnering deal. 
Tags RHHBY Pharmaceuticals Earnings
From MarketWatch
Thursday's biggest gaining and declining stocks
WASHINGTON (MarketWatch) - Shares of the following companies were among those making notable moves in the U.S. stock market Thursday: 
Tags ELN CIT XLNX
From MarketWatch
Biogen, Elan lead drug stocks north
Biogen Idec and partner Elan Corp. led drug stocks higher early Thursday after Biogen reported that usage of their multiple sclerosis drug Tysabri had substantially increased over the quarter despite... 
Tags Biotechnology Economy NVS
From MarketWatch
RothmanResearch.com Stock Review for COO, ELN, HOG, FMC, KBH and LEN
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by RothmanResearch.com. 
From Marketwired News Releases
Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
From PR Newswire
Johnson & Johnson posts lower profit
Johnson & Johnson reports moderately lower second-quarter earnings, due largely to increased generic competition for two of its top-selling prescription drugs and decreased demand for its consumer... 
Tags M&A Earnings Pharmaceuticals
From MarketWatch
Elan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
From Business Wire News Releases
Elan to Showcase Its Leadership in Alzheimer’s Disease at Upcoming International Meeting
From Business Wire News Releases
Elan Announces Webcast of Second Quarter 2009 Financial Results
From Business Wire News Releases
TiVo, Elan may hold attention in late trades
Investors may keep TiVo Inc. shares moving Friday evening after a regular-session selloff in the wake of a disappointing court ruling for the pioneer of digital video-recording technology. 
Tags Market News Markets/Exchanges TIVO
From MarketWatch
Johnson & Johnson Pays $1 Billion For 18% Stake In Elan
Shares of Ireland-based Elan Corp. (NYSE: ELN) surged 95 cents to $7.95 after Johnson & Johnson (NYSE: JNJ) paid $1 billion to take an 18% stake in the drug research firm. Johnson & Johnson stock lost... 
From MarketMinute.com Stock News
Johnson & Johnson Pay $1 Billion For 18% Stake In Elan
Shares of Ireland-based Elan Corp. (NYSE: ELN) surged 95 cents to $7.95 after Johnson & Johnson (NYSE: JNJ) paid $1 billion to take an 18% stake in the drug research firm. Johnson & Johnson stock lost... 
From MarketMinute.com Stock News
Elan deal positions J&J ahead of Obamacare
With members of the baby-boom generation hitting retirement age in force in the next few years, drug companies are trying to line up the blockbuster medications that, they hope, will ease their... 
Tags Health/Care JNJ ELN
From MarketWatch
Drug stocks slide; Elan climbs on J&J deal
Drug stocks slid into the red early Thursday while shares of Elan Corp. rallied on news that Johnson & Johnson was making a $1 billion investment in the company. 
Tags XX:DJII M&A Pharmaceuticals
From MarketWatch
Stocks Open Lower on Weak Jobs Report
U.S. employers cut 467,000 jobs in June raising the unemployment rate to 9.5%, a 26-year high. The Dow fell nearly 150 points to 8355 while Nasdaq tumbled 40 points to 1805. 
Tags Market News
From MarketMinute.com Market Updates
Elan rallies as J&J to invest $1 billion-plus
Johnson & Johnson plans to make a $1 billion investment in Irish drugmaker Elan . in exchange for commercial rights to its experimental Alzheimerâ??s disease medications, and will further fund... 
Tags WYE JNJ ELN
From MarketWatch
Payrolls data, Exelon, Lear, GM in focus
U.S. stock market futures extended earlier losses Thursday after the government reported a bigger-than-expected decline in nonfarm payrolls. 
Tags ELN Automobiles JNJ
From MarketWatch
J&J To Invest $1.5 Bln In Elan In Alzheimer's Deal
J&J To Invest $1.5 Bln In Elan In Alzheimer's Deal 
Tags Health Care
From FOX Business
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
From PR Newswire
The following is an investment opinion release issued by Pennystockchaser.com
From PR Newswire
Antigenics looks to foreign regulators before U.S.
Scrappy biotech firm's stock has soared on hopes that it will finally be able to win regulatory approval for a kidney-cancer vaccine. 
Tags ELN Health/Care WYE
From MarketWatch
Bullish Vibes Radiate From Energy Fund
Today’s tickers: XLE, USU, XLP, MYGN, NYX & ELN XLE – Investors were observed making bullish plays on the energy ETF today amid a modest share price rally of less than 1% to $48.17. The August 49... 
Tags XLE USU Uncategorized
From Phil's Stock World
Drug stocks mixed; Myriad tanks on outlook
Drug stocks were mixed Wednesday, while shares of Myriad Genetics Inc. tanked on news that 2009 revenue would come in below its previously issued forecast. 
Tags $BTK Biotechnology ELN
From MarketWatch
TheFortuneFinancial.com Free Market Research on AVT, CHS, RX, ABC, BBI and ELN
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com. 
From Marketwired News Releases
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
From Business Wire News Releases
Elan Reversals Indicate Bearish Sentiment
Today’s tickers: ELN, NOK, WYE, ELX, GERN, VALE, NVDA & EXC ELN – The neuroscience-based biotechnology company headquartered in Dublin, Ireland, jumped onto our ‘most active by options volume’ market... 
Tags ELN WYE EXC
From Phil's Stock World
Drug stocks slide; Biogen falls on PML update
Drug stocks slide into the red as shares of Biogen Idec fall on news that another case of brain disease PML had been discovered in a user of its multiple-sclerosis drug Tysabri. 
Tags Biotechnology Pharmaceuticals $BTK
From MarketWatch
Elan Announces Date of 2009 Annual General Meeting and Changes in Board of Directors
From Business Wire News Releases
AnalystChoice.com Brings You the Best Complimentary Research Report on FMC, ELN, DRI and GIS
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). 
From Marketwired News Releases
< Previous 1 2
...
33 34 35 36 37 38 39 40 41
...
43 44 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.